Poland· PL-100001025

Lamitrin S

A lamotrigine product containing lamotriginum, registered in Poland by GlaxoSmithKline Trading Services Limited. The same ATC class is registered in 18 of our 19 countries.

ATC N03AX09

Checked against URPL (Poland) on September 27, 2026

Informational only — not a medical device.

Compare price across countriesPer daily dose · free account Ask the assistant about lamotriginumAnswers with sources · free account Check interactionsSeverity free · mechanism on Growth

Where it is registered

Lamotrigine is registered in 18 of 19 countries.

Countries holding a registration under ATC N03AX09 (lamotrigine), each read from that country’s own register.

This record: Poland, from URPL (Poland)
10 of them publish a price we can compare per daily dose

Search lamotrigine products by name

Lamotrigine · ATC N03AX09

18 / 19 countries

Belgiumprice
Canada
Czechiaprice
Denmark
Finlandprice
Franceprice
Germany
Icelandprice
Ireland
Italyprice
Japan
Netherlands
Norwayprice
Polandprice
Sweden
Switzerlandprice
United Kingdom
United Statesprice

Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

Price per daily dose

What a daily dose of lamotrigine costs, country by country.

Normalised to the WHO defined daily dose (0.3 g), the median price runs from $0.14 in United States to $4.21 in Switzerland — a ×30 gap.

4 markets with a comparable price for this class
Public list prices, converted to USD at the rate date shown
US figures are pharmacy acquisition cost (CMS NADAC), not retail

Open the full comparison — free account Drug prices for market access

Lamotrigine · price per daily dose (0.3 g)

USD · FX 28 Sept 2026

CH Switzerland$4.21
IT Italy$2.00
FR France$1.69
US United States$0.14 (acquisition cost)

Median listed price per WHO defined daily dose, in each market that publishes a price. US = pharmacy acquisition cost (CMS NADAC), not a retail price. Open the full comparison

The record

At a glance

URPL (Poland)

Active substance: Lamotriginum
Manufacturer: GlaxoSmithKline Trading Services Limited
Country: Poland (PL)
ATC code: N03AX09
ATC class: Lamotrigine
Defined daily dose: 0.3 g, O
Reimbursed: Not published by this register
Source register: URPL (Poland)
Last checked: September 27, 2026

Packs & prices · 9

1 priced

gtin
05909990422302
gtin
05909990787227
gtin
05909990422296
gtin
05909990787210
30 szt.
PLN 18.57
gtin
05909990691128
gtin
05909990691135
gtin
05909990691142
gtin
05909990691159
gtin
05909990691166

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

248 interactions on record for lamotrigine.

Graded by severity as the source publishes them — 68 moderate. Severity grades are free for everyone; mechanism and management come with Growth.

Severity for every pair — free, no plan needed
The source, licence and sync date on every record
Mechanism and what to do for each pair — Growth plan

Check lamotrigine against other medicines How interaction checks work

Lamotrigine · interactions on record

248 records

68 moderate
9 minor
129 info

Most severe, free to view

MetoclopramideA03FA01moderate
DiphenhydraminA04AB05moderate
DronabinolA04AD10moderate
NabiloneA04AD11moderate

42 more interactions with mechanism and management, from a commercially licensed source.

Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.

Mechanism and what to do, in the interaction check

Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Lamotrigine in 16 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All lamotrigine products

Authorised across Europe · EMA

The same active substance is authorised in 29 EEA countries. Names it is sold under:

Austria · Gerolamic, Lamictal
Belgium · Lambipol, Lamictal
Bulgaria · Епитрижин, Ламиктал
Cyprus · Lamictal, Lamosynt
Czechia · Lamictal, Lamotrigin Actavis
Germany · Lamictal, Lamotrigin 1 A Pharma
Denmark · Lamictal, Lamotrigin
Estonia · Lamictal, Lamotrigine Desitin
Spain · Crisomet, Labileno
Finland · Lamictal, Lamotrigin Desitin
France · Lamictal, Lamotrigine
United Kingdom (Northern Ireland) · Lamictal, Lamotrigine
Greece · Dezepil, Lamictal
Croatia · Arvind, Lamal
Hungary · Gerolamic, Lamictal
Ireland · Lamictal, Lamotrigine Desitin
Iceland · Lamictal
Italy · Amaless, Lamictal
Lithuania · Lamictal
Luxembourg · Lambipol, Lamictal
Latvia · Lamictal, Lamotrix
Malta · Lamictal, Lamotrigine Aurobindo
Netherlands · Lambipol, Lamictal
Norway · Lamictal, Lamotrigin Desitin
Portugal · Lamictal, Lamotrigina Accord
Romania · Lamictal, Lamotrix
Sweden · Lamictal, Lamotrigin
Slovenia · Lamal, Lamictal
Slovakia · Lamictal, Lamotrigin Actavis

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of URPL (Poland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload

GET /v1/drugs/7b2344a8-f79b-42f6-a032-a36ff08520c5
GET /v1/drugs/7b2344a8-f79b-42f6-a032-a36ff08520c5?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Tabletki do rozgryzania i żucia / do sporządzania zawiesiny",
  "source": "urpl",
  "strength": "25 mg",
  "packaging": "05909990787210 ¦ Rp ¦ 197\n30 tabl.\n05909990787227 ¦ Rp ¦ 198\n56 tabl.\n05909990422296 ¦ Rp ¦ 32558\n42 tabl.\n05909990422302 ¦ Rp ¦ 32560\n21 tabl.\n05909990691128 ¦ Rp ¦ 49295\n10 tabl.\n05909990691135 ¦ Rp ¦ 49296\n14 tabl.\n05909990691142 ¦ Rp ¦ 49297\n28 tabl.\n05909990691159 ¦ Rp ¦ 49298\n50 tabl.\n05909990691166 ¦ Rp ¦ 49299\n60 tabl.",
  "substance": "Lamotriginum 25 mg",
  "common_name": "Lamotriginum",
  "pl_product_id": "100001025",
  "pozwolenie_nr": "07872",
  "auth_procedure": "MRP",
  "authorisation_validity": "Bezterminowe"
}

API reference MCP server Plans

See everything about lamotrigine.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it free Open in the console